[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338183-105":59,"doc-detail-338183-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","a-pan-cancer-analysis-of-the-association-of-metrn-with-prognosis-and-immune-infiltration-in-human-tumors-research-article-abstract","A pan-cancer analysis of the association of METRN with prognosis and immune infiltration in human tumors - Research article - abstract","","Meteorin (METRN) is predominantly expressed in the central nervous system, yet its role in tumors remains unclear. This study performs a pan-cancer investigation of METRN expression and evaluates how METRN relates to patient prognosis and immune infiltration. Using UCSC Xena and TCGA datasets, survival and clinical association analyses were conducted, nomogram models built for sarcoma and prostate adenocarcinoma, and functional enrichment performed to explore immune-related pathways.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-pan-cancer-analysis-of-the-association-of-metrn-with-prognosis-and-immune-infiltration-in-human-tumors-research-article-abstract/338183/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-pan-cancer-analysis-of-the-association-of-metrn-with-prognosis-and-immune-infiltration-in-human-tumors-research-article-abstract/338183.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main focus of this pan-cancer study?","Question",{"text":113,"@type":114},"The study examines METRN expression across cancers and analyzes how METRN associates with prognosis and immune infiltration in human tumors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which datasets and tools were used to assess METRN expression and relationships?",{"text":118,"@type":114},"METRN expression was explored using UCSC Xena and TCGA, and additional analyses referenced databases including TCGA, HPA, GEPIA2, and TIMER2.0.",{"name":120,"@type":111,"acceptedAnswer":121},"How did METRN relate to patient prognosis and tumor immune microenvironment?",{"text":122,"@type":114},"METRN showed abnormal expression in multiple tumors and was linked to prognosis and clinical characteristics. Immune infiltration analysis suggested METRN interacts with multiple immune cells, with immune microenvironment changes potentially affecting prognosis.",{"name":124,"@type":111,"acceptedAnswer":125},"What evidence supports METRN as a candidate biomarker or therapeutic target?",{"text":126,"@type":114},"The study reports prognostic value across cancer types and enrichment results pointing to immune-related pathways that may drive tumorigenesis and progression, supporting its potential as a predictive biomarker and immunotherapy target.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},338183,1790795680,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":144,"language":145,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":67,"update_tm":149,"read_time":41,"preview_page_count":19,"preview_urls":150},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Heliyon 10 (2024) e37213  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \n| Research article\u003Cbr>A pan-cancer analysis of the association of METRN with prognosis and immune infiltration in human tumors\u003Cbr>Li Wang a , Guofu Huang b ,* , Han Xiao a , Xiaoling Leng b\u003Cbr>a The Fifth Affiliated Hospital of Xinjiang Medical University, Xinjiang Medical University, Urumqi, China\u003Cbr>b Dongguan Institute of Clinical Cancer Research, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan, China |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>METRN\u003Cbr>Pan-cancer Prognosis Immune infiltration Biomarker |  | Background: Meteorin (METRN) is expressed predominantly in the central nervous system (CNS), where it functions by regulating glial cell differentiation and promoting axonal elongation. Nonetheless, its function within tumors is still not well understood. In this study, we focused on investigating its expression across various cancers and delving deeper into how METRN expression correlates with prognosis and immune infiltration.\u003Cbr>Methods: We explored METRN expression patterns in pan-cancers utilizing data obtained from the UCSC Xena and TCGA. In addition, analyses of survival and clinical association were conducted for tumors where METRN could affect the prognosis. Subsequently, nomogram models were constructed for sarcoma (SARC) and prostate adenocarcinoma (PRAD) to verify METRN’s prognostic value in tumors. Furthermore, we also discussed the link between METRN and immune infiltration. As far as mechanisms are concerned, functional enrichment analysis was conducted to analyze the functional components and signaling pathways involved in METRN.\u003Cbr>Results: This study found that METRN was abnormally expressed in various tumors, closely connected with the prognosis and clinical characteristics of several tumors, and had good prognostic value. Moreover, analysis of immune infiltration revealed that METRN interacts with multiple immune cells, with alterations in the immune microenvironment potentially influencing tumor prognosis. Enrichment analysis indicates that METRN may influence tumorigenesis and progression through immune-related pathways.\u003Cbr>Conclusion: To sum up, our study demonstrates that METRN can be a prospective predictive biomarker in diverse cancer types and a promising target for cancer immunotherapy for pancancer. |\n\n1. Background  \nGlobally, cancer stands as a leading cause of disease and death, placing a considerable burden on both health and the economy of society [1]. Regrettably, the number of new cases is still rising, causing an increased cancer burden [2]. Even though significant efforts have been devoted to improving the diagnosis and treatment of tumors, the outcomes for the majority of tumors remain unsatisfactory [3]. Consequently, it’s critically important to actively seek novel, sensitive biomarkers and alternative therapeutic targets for diagnosing and treating tumors. Pan-cancer analysis refers to the comparison of genetic variants of selected genes across multiple cancers  \n* Corresponding author.  \nE-mail address: [guofuhuang2023@hotmail.com](guofuhuang2023@hotmail.com) (G. Huang).  \n[https://doi.org/10.1016/j.heliyon.2024.e37213](https://doi.org/10.1016/j.heliyon.2024.e37213)  \nReceived 5 May 2024; Received in revised form 16 July 2024; Accepted 29 August 2024 Available online 30 August 2024  \n2405-8440/© 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n[4]. Exploring effective biomarkers in pan-cancer can aid in diagnosing, predicting prognosis, and administering immunot","cbCaivnbn8wodkor","https://ap.wps.com/l/cbCaivnbn8wodkor","pdf",10230601,12,"English","# Background\n## Pan-cancer and biomarker need\n## METRN biology and rationale\n# Methods\n## Data sources and expression analysis\n## Survival, clinical association, and nomograms\n## Immune infiltration linkage and enrichment\n# Results\n## Abnormal METRN expression and prognostic value\n## Immune microenvironment interactions\n## Pathway enrichment\n# Conclusion\n## Predictive biomarker and immunotherapy target","[{\"question\":\"What is the main focus of this pan-cancer study?\",\"answer\":\"The study examines METRN expression across cancers and analyzes how METRN associates with prognosis and immune infiltration in human tumors.\"},{\"question\":\"Which datasets and tools were used to assess METRN expression and relationships?\",\"answer\":\"METRN expression was explored using UCSC Xena and TCGA, and additional analyses referenced databases including TCGA, HPA, GEPIA2, and TIMER2.0.\"},{\"question\":\"How did METRN relate to patient prognosis and tumor immune microenvironment?\",\"answer\":\"METRN showed abnormal expression in multiple tumors and was linked to prognosis and clinical characteristics. Immune infiltration analysis suggested METRN interacts with multiple immune cells, with immune microenvironment changes potentially affecting prognosis.\"},{\"question\":\"What evidence supports METRN as a candidate biomarker or therapeutic target?\",\"answer\":\"The study reports prognostic value across cancer types and enrichment results pointing to immune-related pathways that may drive tumorigenesis and progression, supporting its potential as a predictive biomarker and immunotherapy target.\"}]","A pan-cancer analysis of the association of METRN with prognosis and immune infiltration in human tumors - Research article - abstract | PDF",1790022406,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/777e3fe24a4454dff4cf0e136b83bcc0.webp",983,1341,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6fc8544b76191023dfa7e1925bdf1ae.webp",982,1340,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c05b3bcd9afc17c76ee8a15cac55ada7.webp",981,1338,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efb9cae3efec6dca6553d1aaa660851b.webp",980,1337]